FDA Warns Lilly Over False, Misleading Cymbalta Ads
The FDA has issued a warning to Eli Lilly concerning print ads for its anti-depressant Cymbalta. I’ve not been able to find the letter but have seen multiple press accounts. Here’s what the FDA apparently said.
“‘The print ad is false or misleading in that it presents efficacy claims for Cymbalta, but fails to adequately communicate the risks associated with its use,’ the FDA said. ‘The Blue Book Message is false or misleading because it overstates the efficacy of Cymbalta and minimizes the risks associated with the drug.’”
Risks associated with an anti-depressant? A pharma company downplaying risks? I’ve never heard of such a thing!
Related posts:
Posted in Furious Seasons